Conquer Cancer, the ASCO Foundation, is a 501(c)(3) nonprofit organization based in Alexandria, Virginia. As the philanthropic arm of the American Society of Clinical Oncology (ASCO), the foundation raises and distributes funds to support innovative cancer research, education, and quality improvement programs globally. The organization operates as a global community of advocates, patients, doctors, researchers, caregivers, and others dedicated to improving the lives of people affected by cancer.
Financial Overview
From 2024 IRS Form 990-PF · View filing
Total Assets
$120.7M
+9.7% YoY
Annual Giving
$17.4M
-3.4% YoY
Grant Count
39
+0.0% YoY
Avg Grant Size
$447K
-3.4% YoY
Mission & Focus Areas
Mission: Accelerate breakthroughs in lifesaving research and empower people everywhere to conquer cancer.
Vision: A world where cancer is prevented or cured, and every survivor is healthy.
Tagline: Every Cancer. Every Patient. Everywhere.®
The foundation supports research across the entire spectrum of cancer-related activities, including cancer prevention, screening, treatment, and outcomes research in all cancer types. As the largest funder of early-career researchers without geographic or focus area limitations, Conquer Cancer prioritizes cultivating the next generation of cancer researchers and supporting high-quality clinical and translational research.
Grantmaking
Conquer Cancer operates a comprehensive Grants and Awards program that has been recognizing excellence in clinical research, quality care, and teaching in oncology since 1984.
Ready to take the next step with Conquer Cancer Foundation of the?
Geographic Focus
Where this funder awards grants
Conquer Cancer funds research globally across 96 countries, with particular emphasis on supporting researchers in low- and middle-income countries through dedicated programs like the International Development and Education Award.
Grant Distribution by State
States
Cities
Financial History
Multi-year comparison from IRS filings
As of 2024:
- Total Assets: $120,676,056
- Total Revenues: $41,435,619
- Total Expenses: $34,781,420
- Total Giving: $18,795,488
Tax Status: 501(c)(3) organization; donations are tax-deductible. IRS ruling year: 1999. EIN: 31-1667995.
| Metric | 2024 | 2023 | 2022 |
|---|---|---|---|
| Total Assets | $120,676,056 | $110,051,603 | $98,117,170 |
| Revenue | $41,435,619 | $39,096,707 | $33,133,692 |
| Expenses | $34,781,420 | $33,575,680 | $32,888,928 |
| Qualifying Distributions | — | — | — |
| Net Investment Income | $3,994,373 | $3,429,291 | $1,837,688 |
| Distributable Amount | — | — | — |
Giving Over Time
Total grant dollars and number of grants per year
Grant Insights
How this funder distributes its grants
Top Recipients
Top 10 recipients in 2024
Grant Size Distribution
211 grants across all recorded years
Open Grants
9 open opportunities from Conquer Cancer Foundation of the
ASCO Annual Meeting Merit Awards
CONQUER CANCER FOUNDATION OF THE
Amount
Varies
Deadline
Rolling / Open
ASCO Breakthrough Summit Abstract Awards
CONQUER CANCER FOUNDATION OF THE
Amount
Varies
Deadline
Rolling / Open
ASCO Breakthrough Summit Merit Awards
CONQUER CANCER FOUNDATION OF THE
Amount
Varies
Deadline
Rolling / Open
Giving History
Grant recipients and amounts by year
Among its reported 2024 grants, the largest include American Society of Clinical Oncology Inc ($7,681,670), Memorial Sloan Kettering Cancer Center ($1,415,000), Dana-farber Cancer Institute ($1,000,000).
| Recipient | Purpose | Amount |
|---|---|---|
| AMERICAN SOCIETY OF CLINICAL ONCOLOGY INC ALEXANDRIA, VA | CHARITABLE ASSISTANCE | $7,681,670 |
| BAYLOR COLLEGE OF MEDICINE HOUSTON, TX | YOUNG INVESTIGATOR AWARD, CAREER DEVELOPMENT AWARD | $250,000 |
| BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE DUARTE, CA | YOUNG INVESTIGATOR AWARD | $50,000 |
| CHILDREN'S HOSPITAL OF PHILADELPHIA PHILADELPHIA, PA | YOUNG INVESTIGATOR AWARD | $100,000 |
| CITY OF HOPE DUARTE, CA | CAREER DEVELOPMENT AWARD | $200,000 |
| COLUMBIA UNIVERSITY NEW YORK, NY | YOUNG INVESTIGATOR AWARD, CAREER DEVELOPMENT AWARD | $400,000 |
| DANA-FARBER CANCER INSTITUTE BOSTON, MA | YOUNG INVESTIGATOR AWARD, CAREER DEVELOPMENT AWARD, ADVANCED CLINICAL RESEARCH AWARD | $1,000,000 |
| DUKE UNIVERSITY DURHAM, NC | YOUNG INVESTIGATOR AWARD | $100,000 |
| EMORY UNIVERSITY ATLANTA, GA | YOUNG INVESTIGATOR AWARD | $50,000 |
| FRED HUTCHINSON CANCER CENTER SEATTLE, WA | YOUNG INVESTIGATOR AWARD | $150,000 |
Leadership & Key People
Leadership team and compensation from IRS filings
- Nancy Daly — Chief Executive Officer, Conquer Cancer, the ASCO Foundation
- Clifford A Hudis, MD, FACP, FASCO — Executive Vice Chair, Conquer Cancer, the ASCO Foundation and ASCO Chief Executive Officer
Compensation Overview
From 2024 IRS filing
From 2024 filing
| Name | Title | Hours | Compensation |
|---|---|---|---|
| CLIFFORD A HUDIS MD | EXECUTIVE VICE CHAIR | 6.5 | — |
| HOWARD A BURRIS III MD | BOARD CHAIR | 1 | — |
| ALEXANDER W CASDIN | TREASURER | 1 | — |
| AMY C PETERSON MD | SECRETARY | 1 | — |
| TERESA ALONSO THOMPSON | BOARD MEMBER | 1 | — |
| KATHRYN BEAL MD | BOARD MEMBER | 1 | — |
| WILLIAM BEHNKE | BOARD MEMBER | 1 | — |
| RICCARDO BRAGLIA | BOARD MEMBER | 1 | — |
| OTIS BRAWLEY MD | BOARD MEMBER | 1 | — |
| LAWRENCE H EINHORN MD | BOARD MEMBER | 1 | — |
| JASMINE FERRER MD | BOARD MEMBER | 1 | — |
| RAJ MANTENA RPH | BOARD MEMBER | 1 | — |
| THOMAS A MARSLAND MD | BOARD MEMBER | 1 | — |
| ROBERT J MAYER MD | BOARD MEMBER | 1 | — |
| GERALD J MCDOUGALL | BOARD MEMBER | 1 | — |
| ANNE MOORE MD | BOARD MEMBER | 1 | — |
| STEVEN T ROSEN MD | BOARD MEMBER | 1 | — |
| ALEXANDRA SHAPIRO | BOARD MEMBER | 1 | — |
| SANDRA SWAIN MD | BOARD MEMBER | 1 | — |
| MARGARET A TEMPERO MD | BOARD MEMBER | 1 | — |
| DEANNA B VAN GESTEL | BOARD MEMBER | 1 | — |
| MELINDA O'LEARY | CFO (PARTIAL YEAR) | 1 | — |
| NANCY DALY MS MPH | CEO & EXECUTIVE VP | 36.5 | — |
Recent News & Activity
Recent developments and announcements
Conquer Cancer announced the 2026 International Development and Education Award recipients, supporting early-career oncology professionals in low- and middle-income countries with funding, mentorship, and networking opportunities
Conquer Cancer Foundation will distribute more than $11 million through overEveryGrant initiative announced Quality Improvement grants funded by Pfizer to leverage technology for improving biomarker-driven testing and treatment
Conquer Cancer\u2019s EveryGrant announces Quality Improvement grants, funded\Foundation continues to support more than 9,800 researchers and oncologists globally working on cancer prevention, treatment, and care improvements
Conquer Cancer Foundation will distribute more than $11 million through overSubject Areas
Focus areas based on grantmaking activity
Frequently Asked Questions
What does Conquer Cancer Foundation of the fund?
**Mission:** Accelerate breakthroughs in lifesaving research and empower people everywhere to conquer cancer. **Vision:** A world where cancer is prevented or cured, and every survivor is healthy. **Tagline:** Every Cancer. Every Patient. Everywhere.® The foundation supports research across the entire spectrum of cancer-related activities, including cancer prevention, screening, treatment, and outcomes research in all cancer types. As the largest funder of early-career researchers without geogr…
How do I apply for a grant from Conquer Cancer Foundation of the?
Conquer Cancer operates a comprehensive Grants and Awards program that has been recognizing excellence in clinical research, quality care, and teaching in oncology since 1984. **Scale of Support:** • $203 million+ distributed through the Grants and Awards program to support cancer research worldwide • $500 million+ raised to support research, education, and quality programs • 9,800+ grants and awards provided to recipients since 1984 • Over $158 million in cancer research funded for 2,600 recip…
Where does Conquer Cancer Foundation of the make grants?
Conquer Cancer funds research globally across 96 countries, with particular emphasis on supporting researchers in low- and middle-income countries through dedicated programs like the International Development and Education Award.
What size grants does Conquer Cancer Foundation of the award?
In 2024, Conquer Cancer Foundation of the awarded 39 grants totaling $17.4M — an average of about $447K per grant, based on its IRS Form 990 filings.
What is Conquer Cancer Foundation of the's EIN?
Conquer Cancer Foundation of the's EIN (Employer Identification Number) is 31-1667995. IRS Form 990 filing data is available on this page for 2020–2024.
Explore Open Grants
Browse active grant opportunities in Conquer Cancer Foundation of the's focus areas in our free grants database
Similar Funders
Funders that support many of the same organizations
American Heart Association Inc
DALLAS, TX
Assets
$1.9B
Grants
794
Total Given
$227.6M
American Cancer Society Inc
ATLANTA, GA
Assets
$1.7B
Grants
688
Total Given
$197.1M
Vanderbilt University Medical Center
NASHVILLE, TN
Assets
$6.6B
Grants
234
Total Given
$112.3M
Morgan Stanley Global Impact Funding Trust Inc
INDIANAPOLIS, IN
Assets
$9.1B
Grants
19,253
Total Given
$1.2B
Emory University
ATLANTA, GA
Assets
$22.2B
Grants
352
Total Given
$240.1M
Vanguard Charitable Endowment Program
SOUTHEASTERN, PA
Assets
$22.2B
Grants
24,269
Total Given
$3.0B
National Philanthropic Trust
JENKINTOWN, PA
Assets
$42.2B
Grants
18,583
Total Given
$5.1B
Yale University
NEW HAVEN, CT
Assets
$55.2B
Grants
344
Total Given
$137.2M
Cystic Fibrosis Foundation
BETHESDA, MD
Assets
$5.0B
Grants
624
Total Given
$189.6M
Bristol-myers Squibb Foundation Inc
PRINCETON, NJ
Assets
$83.3M
Grants
144
Total Given
$67.7M
Mayo Clinic
ROCHESTER, MN
Assets
$26.7B
Grants
256
Total Given
$572.1M
Northwestern University
EVANSTON, IL
Assets
$19.2B
Grants
375
Total Given
$122.4M
Data last updated June 2026. Sourced from IRS Form 990-PF filings. Research dossier generated April 2026.
What could you do with Conquer Cancer Foundation of the on Grantable?
- Assess strategic fit with your organization
- Draft a tailored letter of inquiry
- Find open RFPs from this funder
- Monitor for new funding opportunities
Go from researching Conquer Cancer Foundation of the to a real strategy.